Harbin Pharmaceutical’s Health Products Revenue reached 410 million yuan
date：2018-05-10
browse：（835）
Keyword：
In 2017, Harbin Pharmaceutical Co., Ltd. (600664) realized operating revenue of RMB 12.018 billion, a year-on-year decrease of 14.93%, and net profit of RMB 407 million, a decrease of 48.36% year-on-year. The revenue of health products business was 410 million yuan, down 38.73% compared to last year.
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
